Invesaro

Stocks Health care RMTI

NASDAQ · Health care

Rockwell Medical, Inc. (RMTI)

Rockwell Medical, Inc. brought in $69.4M of revenue over the twelve months to June 30, 2026, down 21.1% from a year earlier. It posted a net loss of $5.1M. In fiscal 2025 capital spending exceeded operating cash flow by $1.2M. At June 30, 2026 it held $10.5M in cash against $9M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

Watch RMTI in 60 seconds
Price
$8.37
-2.33% on the day · September 25, 2026
52-week range $4.89 to $12.90
Market cap
$33.7M
Revenue (last 12 months)
$69.4M
-21.1% year on year
Net margin
-7.3%

What Rockwell Medical, Inc. does

Rockwell Medical, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker RMTI.

Revenue and profit by year

Revenue
FY18: $63.4M $63.4M FY18FY19: $61.3M $61.3M FY19FY20: $62.2M $62.2M FY20FY21: $61.9M $61.9M FY21FY22: $72.8M $72.8M FY22FY23: $83.6M $83.6M FY23FY24: $101.5M $101.5M FY24FY25: $69.3M $69.3M FY25
Net income
FY18: -$32.1M -$32.1M FY18FY19: -$34.1M -$34.1M FY19FY20: -$30.9M -$30.9M FY20FY21: -$32.7M -$32.7M FY21FY22: -$18.7M -$18.7M FY22FY23: -$8.4M -$8.4M FY23FY24: -$480K -$480K FY24FY25: -$5.3M -$5.3M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$69.3M-$4.7M-$5.3M-$0.15-$1.2M
2024$101.5M$608K-$480K-$0.03$3.2M
2023$83.6M-$6.7M-$8.4M-$0.37-$9.7M
2022$72.8M-$16.8M-$18.7M-$1.31n/a
2021$61.9M-$30.3M-$32.7M-$2.65n/a
2020$62.2M-$28.4M-$30.9M-$3.11n/a

Full financial statements: income, balance sheet and cash flow

Next report expected around November 11, 2026.

Estimated from its filing rhythm: 52 weeks after its report of November 12, 2025. Not a date the company has announced. See the report calendar

Where RMTI ranks in Health care

Revenue$69.3M
#345 of 646 in Health care · Bottom 47%
Revenue growth-31.8%
#450 of 474 in Health care · Bottom 5%
Net margin-7.7%
#240 of 485 in Health care · Top 49%
Free cash flow margin-1.7%
#230 of 440 in Health care · Bottom 48%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What Rockwell Medical, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 13, 2026
  2. August 13, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 11% to $17.8M versus the same quarter last year; diluted EPS -$0.34 versus -$0.05.
  3. August 13, 2026
  4. July 20, 2026
  5. June 29, 2026
  6. June 15, 2026
  7. May 11, 2026
  8. May 8, 2026
  9. May 7, 2026
  10. May 7, 2026
    Quarterly report 10-Q · period to March 31, 2026Revenue fell 8.3% to $17.3M versus the same quarter last year; diluted EPS -$0.04 versus -$0.04.

Recent insider filings (Forms 3, 4 and 144): 10, the latest on July 6, 2026. Insider transactions on SEC

Insider trades

What the people running Rockwell Medical, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider bought or sold shares on the open market in the last 90 days. The 10 reported changes were pay in shares, option exercises, shares withheld for tax or gifts.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
July 1, 2026 Strobeck MarkPresident and CEO, Director Received as pay 30,000 - - Form 4
July 1, 2026 Neri JesseSVP and CFO Received as pay 15,000 - - Form 4
July 1, 2026 Timmins Megan C.EVP, CLO & Secretary Received as pay 15,000 - - Form 4
July 1, 2026 Hunter HeatherChief Operating Officer Received as pay 15,000 - - Form 4
July 1, 2026 Chole TimothySVP and CCO Received as pay 15,000 - - Form 4
July 1, 2026 Cooper John GDirector Received as pay 9,633 - - Form 4
July 1, 2026 Radie Robert SDirector Received as pay 9,633 - - Form 4
July 1, 2026 Lau JoanDirector Received as pay 9,633 - - Form 4
July 1, 2026 Nissenson AllenDirector Received as pay 9,633 - - Form 4
July 1, 2026 Dawson Joseph HDirector Received as pay 9,633 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns RMTI

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Irrevocable Larson Family Investment Trust13G, passive 10.7% 3,470,000 December 17, 2024

Latest filings below 5%: Armistice Capital, LLC 4.99% (November 14, 2025).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

10 insiders reported holding 280,744 shares in total, about $2.3M at the last price.

HolderSharesAs of
Strobeck MarkPresident and CEO, Director 62,349 July 1, 2026
Timmins Megan C.EVP, CLO & Secretary 31,240 July 1, 2026
Hunter HeatherChief Operating Officer 28,007 July 1, 2026
Chole TimothySVP and CCO 27,285 July 1, 2026
Neri JesseSVP and CFO 27,239 July 1, 2026
Radie Robert SDirector 23,985 July 1, 2026
Nissenson AllenDirector 23,892 July 1, 2026
Cooper John GDirector 23,670 July 1, 2026
Lau JoanDirector 20,944 July 1, 2026
Dawson Joseph HDirector 12,133 July 1, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about RMTI

What does Rockwell Medical, Inc. do?

Rockwell Medical, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker RMTI.

Is Rockwell Medical, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $5.1M on revenue of $69.4M.

How much revenue does Rockwell Medical, Inc. make?

Over the twelve months to June 30, 2026 Rockwell Medical, Inc. reported revenue of $69.4M. That is 21.1% less than a year earlier.

When did Rockwell Medical, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026.

Similar companies

Compare RMTI with

Compare RMTI with any company

Follow RMTI

Get an email when Rockwell Medical, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow RMTI: get an email when it files

Where the numbers come from

Financial figures are the values Rockwell Medical, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.